SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190870

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190870

Shock Wave Therapy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Shock Wave Therapy Devices Market reached USD 195.2 million in 2025 and is projected to grow at 4.6% CAGR from 2026 to 2035. The market is expected to cross USD 306.2 million valuation by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$195.2 Million
Forecast Value$306.2 Million
CAGR4.6%

Musculoskeletal conditions support demand beyond specialist sports practices. Hospitals, rehabilitation providers, and outpatient facilities use shock wave approaches within pathways for chronic tendon problems and related conditions. Compact equipment can suit smaller treatment settings, creating initial purchases alongside replacement at established institutions. Urolithiasis provides a different source of demand. Hospitals assess lithotripters within capital plans, considering imaging compatibility, utilization, and service. Mature systems generate replacements, while developing secondary and tertiary networks create opportunities for new installations. Broader wound-care indications add another route to procurement. Manufacturers need to demonstrate practical value within wound, dermatology, and plastic-surgery workflows rather than assuming existing orthopedic relationships will automatically convert into demand. The drivers therefore connect a recurring clinical base with new settings and applications. Suppliers must support clinical education, suitable configurations, and dependable service, matching the platform to how a department will actually use it and the reimbursement or purchasing arrangements governing its investment.

Based on technology, Focused ESWT is projected to reach USD 125.5 million by 2035. Precise targeting supports orthopedic, wound, and selected cardiac applications. Planning and imaging integration add relevance in complex clinical environments. Suppliers can address providers requiring controlled acoustic delivery within specialized pathways, connecting the technical platform with the information and treatment coordination needed to use it effectively across different indications.

By application, orthopedic uses are projected to reach USD 150.0 million by 2035. Chronic tendon and soft-tissue conditions create demand for non-invasive options through rehabilitation, sports medicine, and hospital channels. Providers seek approaches that may defer injections or surgery within appropriate pathways. Equipment purchasing therefore reflects both the clinical caseload and the ability to incorporate treatment into existing services, making training and practical support relevant alongside device capability.

The North America shock wave therapy devices market is projected to generate USD 107.5 million by 2035. Hospitals, established lithotripsy, and planned capital replacement support demand. Orthopedic reimbursement varies and influences use in elective care. Suppliers need to address this difference between applications, connecting technology and service with the economic conditions governing hospital equipment and outpatient treatment rather than relying on a uniform regional purchasing proposition.

Storz Medical AG held over 14.0% market share in 2025. A portfolio covering focused and radial systems supports musculoskeletal, orthopedic, rehabilitation, and urological uses. This breadth provides access to several care settings. Installed relationships, clinical support, and training remain important, helping connect equipment with the procedures and operating requirements through which providers evaluate continuing use and future replacement.

Some of the major players in this market are EMS Electro Medical Systems (DolorClast), Olympus Corporation, BTL Corporate, Siemens Healthineers, and Dornier MedTech. Zimmer MedizinSysteme contributes radial pressure-wave and rehabilitation products supported by reliability and service. Other medical technology companies retain relevance through hospital relationships, related devices, and acoustic expertise, although their direct exposure varies. Specialists and diversified businesses therefore compete through different strengths. Clinical evidence, indication coverage, physician engagement, and after-sales support influence selection more than size alone. Customers need platforms suited to hospital capital processes or smaller outpatient services, with procurement requirements differing accordingly. Suppliers able to demonstrate practical use within a defined clinical pathway can maintain focused positions. This makes application knowledge and support central to competition, particularly as indications broaden beyond the traditional departments in which shock wave systems first established their commercial presence. Dedicated rehabilitation suppliers can maintain positions through reliable products and close clinician support. This focused approach complements larger portfolios where buyers prioritize practical treatment workflows and accessible servicing within a defined outpatient specialty.

Product Code: 3189

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Technology trends
    • 2.2.2 Application trends
    • 2.2.3 Type trends
    • 2.2.4 End use trends
    • 2.2.5 Regional trends
  • 2.3 TAM analysis, 2027-2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factors affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of musculoskeletal disorders
      • 3.2.1.2 Technological advancements in shock wave therapy devices
      • 3.2.1.3 Rising number of sports injuries
      • 3.2.1.4 Growing preference for non-invasive treatments
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of shock wave therapy devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Rising demand in aesthetic and dermatology applications
  • 3.3 Growth potential analysis
  • 3.4 Pricing Analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus)
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia-Pacific
    • 3.5.4 Latin America
    • 3.5.5 Middle East and Africa
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Trade Data Analysis (Based on Paid Database)
    • 3.8.1 Import/Export Volume & Value Trends
    • 3.8.2 Key Trade Corridors & Tariff Impact
  • 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
    • 3.9.1 AI-Driven Disruption of Existing Business Models
    • 3.9.2 GenAI Use Cases & Adoption Roadmap by Segment
    • 3.9.3 Risks, Limitations & Regulatory Considerations
  • 3.10 Patent / IP Landscape
  • 3.11 Medical Infrastructure Landscape
  • 3.12 Epidemiology / Disease Burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia-Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East and Africa
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Technology, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Focused shockwave generation
    • 5.2.1 Electrohydraulic shock wave generation (EHSG)
    • 5.2.2 Piezoelectric shock wave generation (PSG)
    • 5.2.3 Electromagnetic shock wave generation (EMSG)
  • 5.3 Radial or ballistic shock wave generation
  • 5.4 Combined shock wave generation

Chapter 6. Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Orthopedic
  • 6.3 Cardiology
  • 6.4 Urology
  • 6.5 Other applications

Chapter 7. Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Fixed

Chapter 8. Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Diagnostic laboratories
  • 8.4 Ambulatory surgical centers

Chapter 9. Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia-Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10. Company Profiles

  • 10.1 Global Players
    • 10.1.1 BD
    • 10.1.2 Boston Scientific
    • 10.1.3 Johnson & Johnson
    • 10.1.4 LUMENIS
    • 10.1.5 OLYMPUS
    • 10.1.6 SIEMENS Healthineers
  • 10.2 Regional Players
    • 10.2.1 BTL
    • 10.2.2 Dornier MedTech
    • 10.2.3 EMS
    • 10.2.4 Zimmer MedizinSysteme
  • 10.3 Emerging Players
    • 10.3.1 Focal One
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!